Abbott Laboratories (ABT) vs AstraZeneca PLC (AZN)
AZN leads on 11 of 17 compared metrics, though ABT is the cheaper stock.
A side-by-side comparison of Abbott Laboratories and AstraZeneca PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABT vs AZN
growth of $100 · last 30yABT +814.7%AZN +731.4%ABT compounded faster
ABT AZN
ABT vs AZN: by the numbers
- •AZN is the larger company ($277.22B vs $153.59B market cap).
- •ABT trades at the lower earnings multiple (24.56 vs 26.92 P/E).
- •AZN converts more revenue to profit (17.19% vs 13.91% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 3.87% CAGR).
- •ABT pays the higher dividend yield (2.77% vs 1.79%).
Which is better, ABT or AZN?
Metric tally: ABT 6 · AZN 11It depends on what you're optimizing for:
ValueABT(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeABT(higher dividend yield)
QualityAZN(higher ROIC)
Valuation
| Metric | ABT | AZN |
|---|---|---|
| P/E ratio | 24.56● | 26.92 |
| Forward P/E | 14.56● | 15.33 |
| P/S ratio | 3.41● | 4.62 |
| P/B ratio | 2.96● | 5.90 |
| PEG ratio | 2.99 | 0.14● |
| EV / EBITDA | 17.30 | 14.92● |
| FCF yield | 4.79%● | 2.89% |
Profitability
| Metric | ABT | AZN |
|---|---|---|
| Gross margin | 56.38% | 81.68%● |
| Operating margin | 18.17% | 23.69%● |
| Net margin | 13.91% | 17.19%● |
| ROE | 12.06% | 21.95%● |
| ROIC | 8.43% | 13.03%● |
Dividends
| Metric | ABT | AZN |
|---|---|---|
| Dividend yield | 2.77%● | 1.79% |
| Payout ratio | 65.24% | 48.48% |
Growth (annualized)
| Metric | ABT | AZN |
|---|---|---|
| Revenue CAGR (5Y) | 3.87% | 16.99%● |
| EPS CAGR (5Y) | 8.22% | 22.02%● |
| FCF CAGR (5Y) | -0.61% | 15.68%● |
| Total return CAGR (5Y) | -2.49% | 11.03%● |
Frequently asked
- Which is better, ABT or AZN?
- It depends on your goal. value: ABT (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: ABT (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 11 to 6.
- Is ABT or AZN cheaper?
- On trailing earnings, ABT is cheaper: ABT trades at a 24.56 P/E and AZN at 26.92.
- Which has grown faster, ABT or AZN?
- Over the past five years, AZN grew revenue faster — ABT at a 3.87% CAGR versus AZN at 16.99%.
- Does ABT or AZN pay a bigger dividend?
- ABT yields 2.77% and AZN yields 1.79% based on trailing dividends and the latest price.
- Is ABT or AZN more profitable?
- AZN runs the higher net margin — ABT at 13.91% versus AZN at 17.19%.
- Which has been the better investment, ABT or AZN?
- Over the past 10-year, AZN delivered the higher annualized total return — ABT at 10.72% versus AZN at 15.77%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioAstraZeneca P/E ratioAbbott Laboratories dividend yieldAstraZeneca dividend yieldAbbott Laboratories ROEAstraZeneca ROEAbbott Laboratories operating marginAstraZeneca operating marginAbbott Laboratories revenue growthAstraZeneca revenue growthAbbott Laboratories free cash flowAstraZeneca free cash flow
Abbott Laboratories & AstraZeneca appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.